Efficacy of retrograde revascularization in diabetic patients with chronic limb-threatening ischemia after a failed

Marco Nezzo1, Marco Meloni2, Alessandro Carini1

  • 1Interventional Radiology Unit, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Roma, Italy.

Vascular
|May 30, 2024
PubMed

Insights

Retrograde recanalization of below-the-knee vessels is a safe and effective treatment for diabetic patients with chronic limb-threatening ischemia when an antegrade approach fails. This technique offers high success rates and a good survival rate, making it a valuable option.

Area of Science:

  • Vascular Surgery
  • Endovascular Interventions
  • Diabetic Limb Complications

Background:

  • Chronic limb-threatening ischemia (CLTI) is the advanced stage of peripheral arterial disease (PAD).
  • Revascularizing below-the-knee (BTK) vessels in diabetic patients with chronic total occlusions (CTOs) is challenging, often impossible via antegrade transfemoral approach alone.
  • Limited literature exists on the effectiveness of retrograde approaches for BTK occlusions in diabetic patients.

Purpose of the Study:

  • To retrospectively evaluate the safety, technical success, and clinical outcomes of retrograde transpedal/transtibial recanalization in diabetic patients with CLTI.
  • To assess the efficacy of the retrograde approach as an alternative when antegrade revascularization fails.

Main Methods:

  • Retrospective observational monocentric study analyzing 28 diabetic patients who underwent retrograde BTK revascularization after failed antegrade transfemoral attempts.
  • Data collected included comorbidities, disease classification (Rutherford- ते-Becker, Texas), occluded vessel characteristics, and procedural details.
  • Evaluated technical success, procedural success, complication rates, limb salvage, and survival at 6-month follow-up.

Main Results:

  • High technical success (89.3%) and procedural success (82.1%) were achieved with no complications at the pedal/tibial access site.
  • A 6-month cure rate of 57.1% and a 6-month survival rate of 96.4% were observed.
  • Major amputations occurred in 10.7% and minor amputations in 14.2% of patients.

Conclusions:

  • Retrograde transpedal/transtibial recanalization is a safe and effective strategy for BTK revascularization in diabetic patients with CLTI.
  • The technique demonstrates high procedural and clinical success rates with minimal complications.
  • It should be strongly considered when antegrade transfemoral revascularization is not feasible.